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Brachial plexus injury often involves traumatic root avulsion resulting in permanent paralysis of the innervated muscles. The lack
of sufficient regeneration from spinal motoneurons to the peripheral nerve (PN) is considered to be one of the major causes of
the unsatisfactory outcome of various surgical interventions for repair of the devastating injury. The present study was undertaken
to investigate potential inhibitory signals which influence axonal regeneration after root avulsion injury. The results of the study
showed that root avulsion triggered GSK-3𝛽 activation in the injured motoneurons and remaining axons in the ventral funiculus.
Systemic application of a clinical dose of lithium suppressed activated GSK-3𝛽 in the lesioned spinal cord to the normal level and
induced extensive axonal regeneration into replanted ventral roots. Our study suggests that GSK-3𝛽 activity is involved in negative
regulation for axonal elongation and regeneration and lithium, the specific GSK-3𝛽 inhibitor, enhances motoneuron regeneration
from CNS to PNS.
1. Introduction
Over 50 years ago, lithium was discovered to be efficacious
in treatment of bipolar disorders and it remains one of
the primary antidepressant drugs. Recently, accumulating
evidence suggests that lithium has more significant clini-
cal implications for treating neurological disorders includ-
ing Alzheimer’s disease, Parkinson’s disease, ischemic brain
injury,Huntington’s disease, and amyotrophic lateral sclerosis
because of its potent neuroprotective and neurogenesis-
promoting ability [1–5]. Moreover, it has been shown that
treatment with a clinical dose of lithium to rats with tho-
racic spinal cord transaction of contusions injuries induces
significant descending corticospinal and serotonergic axon
regeneration and promotes locomotor functional recovery
[6], indicating that lithium can be applied to treat traumatic
injury to the spinal cord. With the development of research
work into lithium’s actions, it is believed that lithium applica-
tion can be expanded to more neurological diseases.
Although it is believed that motoneurons can regenerate
following peripheral nerve injury, the number of regenerating
motoneurons isminimal and is not enough for full functional
recovery. Brachial plexus injury often involves avulsion of
several nerve roots from the cervical spinal cord, leading
to massive motoneuron death and permanent paralysis of
the innervated muscles [7–10]. Various approaches focusing
onmicrosurgical interventions have been extensively studied
to restore target innervation and functional recovery after
avulsion [11–15]. However, the treatment for the devastating
injury is still a challenging clinical and surgical problem.The
challenge which lies in the brachial plexus injury treatment is
that motoneuron death in the lesioned segments is relatively
high and little is known about how inhibitory signals or lack
of appropriate guidance molecules influences regeneration.
In the present study, we investigated the potential roles
of lithium in treatment of brachial plexus injury with root
avulsion. Our study shows that lithium treatment markedly
reduced the activation of GSK-3𝛽 triggered by root avulsion
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and enhanced dendritic emanation and axonal regeneration
of injured motoneurons after ventral root replantation. The
results of the present study demonstrate for the first time
that root avulsion stimulates the activation of GSK-3𝛽 in the
injured spinal cord and inactivation of GSK 3𝛽 by lithium
treatment has beneficial effects on motoneuron regeneration
after brachial plexus injury.
2. Materials and Methods
All surgical interventions and subsequent care and treatment
were approved by the Committee on the Use of Live Animals
for Teaching and Research of the University of Hong Kong.
2.1. GSK-3𝛽 Activity Assays in the Avulsion-Injured Spinal
Cord. Twelve adult female Sprague-Dawley rats (220–250 g)
were anesthetized with an intraperitoneal injection of
ketamine (80mg/kg) and xylazine (8mg/kg). Root avulsion
was performed as described previously [16, 17]. Briefly, a
dorsal hemilaminectomyon the right side of the sixth cervical
vertebra was carried out under aseptic conditions. The 7th
cervical spinal roots (C7) were avulsed by traction with a
fine hook under a surgical microscope. Total avulsion was
checked by visual inspection. Immediately after root avulsion,
the animals were randomly divided into 2 groups (6 animals
in each group) which received either an intraperitoneal
injection of lithium chloride (85mg/kg bodyweight) [18] or
saline as the control. Twenty-four hours after injury, all the
animals were perfused intracardially with cold 0.01MPBS for
5min. To evaluate activated GSK-3𝛽 signals in the avulsed
spinal cord, we directly stained 30𝜇m cross-sections of fixed
C7 segments harvested from the remaining animals with the
antibody against p-GSK-3𝛽Tyr216. The activity of GSK-3𝛽 is
positively regulated by phosphorylation of Tyr216 [19]. Thus
the level of p-GSK-3𝛽Tyr216 represents active GSK-3𝛽.
2.2. Root Avulsion, Ventral Root Replantation, and Axonal
Tracing. Ventral root reimplantation model was used to
investigate potential roles of lithium in treatment of brachial
plexus injurywith root avulsion. Techniques for restoration of
connectivity by reimplantation of avulsed ventral roots have
been extensively developed in animal and humanmodels [11–
15]. In most of these studies, the ventral root was directly
inserted into the spinal cord after an incision was made
in the white matter. Although the insertion site had been
optimized so as to minimize functional disorder of the spinal
cord [14], the possibility of spinal cord injury remained. In
order to avoid damaging the spinal cord by incision, we
have developed a new microsurgical technique in which the
avulsed ventral root was placed on the pial surface of the
spinal cord and the avulsed dorsal root was sutured to the
edge of the dura mater to fix the repositioned ventral root
in place [16, 20]. A total of 27 adult female Sprague-Dawley
rats (220–250 g) underwent this ventral root reimplantation
microsurgery immediately after the right C7 spinal nerve
avulsion. After surgery, the animals were evenly divided into
3 groups (𝑛 = 9 for each group) in which one group
received daily intraperitoneal injection of lithium chloride
(85mg/kg bodyweight), another group received subcuta-
neous injections of a selective GSK-3 inhibitor, SB415286 (SB)
(1mg/kg/d), with syringes (two times per day) [6], and the
third group received saline as the control treatment. Animals
were allowed to survive for 6weeks.Three days before the end
of the survival period, we injected 0.5 𝜇L of 3% FluoroGold
(FG) into the C7 spinal nerve via a Hamilton syringe with the
needle tip sharpened to label the regenerating neurons.
2.3. Histology. At the end of the survival period, the animals
were killed with a lethal dose of sodium pentobarbital
and perfused intracardially with 0.01M PBS, followed by
perfusion with 200–300mL of fixative solution containing
4% paraformaldehyde in 0.1M PB. Spinal cords were har-
vested and postfixed in fresh fixative solution overnight and
subsequently placed in 30% sucrose—0.1M PB at 4∘C for 2-3
days. The C7 segment of the spinal cord was cut into 30 𝜇m
cross-sections on a microtome (American Optical Company,
NY, USA), mounted on the slides, protected by cover slips,
and examined under a fluorescence microscope to count
FG-positive cells. Only labeled neurons with visible nuclei
were counted.Thenwe quantified the survivingmotoneurons
according to a previously described method [21, 22]. Briefly,
one of every other cross-section, totally 25 sections per
animal, was stained with 1% neutral red. Motoneurons were
counted on both sides of the spinal cord. Only those nucle-
olated profiles apparently belonging to motoneurons were
counted to avoid duplication.Thenumber ofmotoneurons on
the intact side was expressed as 100% of the control value.The
number of surviving motoneurons on the lesioned side was
described quantitatively as percentages of the normal control
number.
2.4. Statistical Analyses. Statistical differences between two
groups were determined by two-tailed Student’s 𝑡-test. Multi-
ple group comparisons were made by one-way ANOVA and
Tukey post hoc test. Data were presented as mean ± SEM.
Significance levels were set to 0.05 for all comparisons.
3. Results
3.1. Lithium Treatment Suppressed GSK-3𝛽 Activation Trig-
gered by Root Avulsion. To assess endogenous alterations
of GSK-3𝛽 activity after avulsion injury, we examined the
expression of p-GSK-3𝛽Tyr216 using immunostaining. Positive
immunoreactivity for p-GSK-3𝛽Tyr216 was almost absent in
the ventral funiculus and ventral root exit zone in normal
animals (Figure 1(A)) and around 135 ± 11.6 p-GSK-3𝛽Tyr216-
positive neurons were detected in the normal ventral horn
(Figure 1(A)). The number of p-GSK-3𝛽Tyr216-positive neu-
ronswas significantly increased 24 h after root avulsion (397±
27.2, Figures 1(B) and 1(D); 𝑃 < 0.001 compared with the
normal) and positive immunoreactivity for p-GSK-3𝛽Tyr216
was obviously observed along the ventral funiculus as well
as in the ventral root exit zone (Figure 1(B)), suggesting
that root avulsion triggered the activation of GSK-3𝛽 in
the spinal cord. Treatment with lithium markedly repressed
avulsion-induced GSK-3𝛽 activation to the normal level as
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Figure 1: Lithium treatment suppressed GSK-3𝛽 activation in the avulsion-injured ventral horn. Immunostaining with p-GSK-3𝛽Tyr216 on
cross-sections of the spinal cord of animals: (A) normal animals, (B) animals which received root avulsion, and (C) animals which received
lithium treatment after root avulsion. ((a), (b), (c))The arrow-pointed areas under higher magnifications. (D)The number of p-GSK-3𝛽Tyr216-
positive neurons in the ventral horn at 24 h after root avulsion was significantly increased compared with that in the normal ventral horn and
treatment with lithiummarkedly reduced avulsion-induced GSK-3𝛽 activation to the normal level (∗𝑃 < 0.001; scale bar: 180𝜇m in (A), (B),
and (C); 40𝜇m in (a), (b), and (c)).
shown by a decline in the number of p-GSK-3𝛽Tyr216-positive
neurons and p-GSK-3𝛽Tyr216 immunoreactivity along the
ventral funiculus (156 ± 13.5, Figures 1(C) and 1(D);𝑃 < 0.001
compared with the avulsion group).
3.2. Lithium Treatment Increased Dendritic Emanation and
Axonal Regeneration of Motoneurons after Replantation of
Ventral Roots. During harvesting spinal cords, gross anatom-
ical investigations confirmed that the replanted ventral roots
were firmly attached to the ventrolateral aspect of the spinal
cord in all the 27 animals. Retrograde labeling with FG
showed that regenerating motoneurons extended their axons
into the replanted ventral roots attached to the surface of
avulsed spinal cord in all of the animals (Figures 2(a1), 2(b1),
and 2(c1)). In saline-treated animals, ventral root replantation
induced 703 ± 76.5 FG-positive neurons in the C7 ventral
horn (Figures 2(A) and 2(C)). Notably, systemic application
of lithium led to a dramatic increase in the number of FG-
positive neurons present in the C7 ventral horn (1217 ± 163.9,
Figures 2(B) and 2(C); 𝑃 < 0.001 compared with the saline
group). A dramatic increase in the number of FG-positive
neurons in the C7 ventral horn was also observed in the
animals which received subcutaneous SB injections (1258 ±
178.2, Figures 2(C) and 2(D); 𝑃 < 0.001 compared with the
saline group). Furthermore, both lithium treatment and SB
application induced a significant increase in the number of
dendritic emanation per FG-positive neuron compared with
the saline control (5.8± 1.4 versus 3.1± 0.6 and 5.5± 1.0 versus
3.1 ± 0.6 resp.; 𝑃 < 0.05, Figures 2(a2), 2(b2), 2(c2), and 2(E)).
We then investigated the effect of lithium on motoneu-
rons survival after ventral root replantation. Six weeks after
root avulsion, only 25.6 ± 2.8% of motoneurons survived in
the ventral horn in contrast to the normal side (Figures 3(A)
and 3(B)). Root ventral replantation significantly increased
the number of surviving motoneurons. In saline-treated
animals, 61.2 ± 7.3% of motoneurons survived 6 weeks after
ventral root replantation, which is significantly higher than
that in animals which received avulsion only (𝑃 < 0.001,
Figures 3(C) and 3(E)). In contrast to promoting effects of
lithium on regeneration, lithium treatment did not further
increase the motoneuron survival after ventral root replan-
tation (65.4 ± 8.1%, Figure 3(D)). There were no statistically
significant differences in the survival rate of motoneurons
between saline- and lithium-treated animals (𝑃 > 0.05,
Figure 3(E)).
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Figure 2: Lithium treatment increased axonal regeneration and dendritic emanation of motoneurons after replantation of avulsed ventral
roots. (A) A representative micrograph of spinal cross-sections showing FG-positive neurons (arrows) present in the ventral horn of the
animals with ventral root reimplantation (VRI) plus saline treatment as controls. (a1) Micrographs made under higher magnification of
the rectangular area in A showing that FG-labeled neurons extended their axons into the replanted ventral roots; (a2) micrographs made
under higher magnification of the arrow-pointed area in A showing dendritic emanation of FG-labeled neurons in the ventral horn. (B) A
representative micrograph of spinal cross-sections showing FG-positive neurons (arrows) present in the ventral horn of the animals with
ventral root reimplantation (VRI) plus lithium treatment. (b1) Micrographs made under higher magnification of the rectangular area in B
showing that FG-labeled neurons extended their axons into the replanted ventral roots; (b2) micrographs made under higher magnification
of the arrow-pointed area in B showing dendritic emanation of FG-labeled neurons in the ventral horn. (C) A representative micrograph
of spinal cross-sections showing FG-positive neurons (arrows) present in the ventral horn of the animals with ventral root reimplantation
(VRI) plus SB injection. (c1) Micrographs made under higher magnification of the rectangular area in C showing that FG-labeled neurons
extended their axons into the replanted ventral roots; (c2) micrographs made under higher magnification of the arrow-pointed area in C
showing dendritic emanation of FG-labeled neurons in the ventral horn. (D)The number of regenerating motoneurons that extended axons
into replanted ventral roots in the lithium-treated animals was significantly higher than that in the saline control animals (∗𝑃 < 0.001). (E)
The number of dendritic emanation from regenerating motoneurons in the lithium-treated animals was significantly higher than that in the
saline control animals (#𝑃 < 0.05). Scale bar: 180 𝜇m in A, B, and C; 75 𝜇m in (a1), (a2), (b1), (b2), (c1), and (c2).
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Figure 3: Effects of lithium treatment and ventral root reimplantation (VRI) on the survival of host motoneurons as revealed by neutral
red staining 6 weeks after root avulsion. (A) Normal animals. (B) Animals receiving root avulsion only. (C) Animals receiving ventral
root reimplantation (VRI) plus saline injection. (D) Animals receiving ventral root reimplantation (VRI) plus lithium treatment. (E) VRI
significantly increased the survival rate of motoneurons compared to controls (∗𝑃 < 0.001 compared to root avulsion only). Lithium
treatment did not further increase the motoneuron survival after VRI. There were no statistically significant differences in the survival rate
of motoneurons between saline- and lithium-treated animals. Scale bar: 150 𝜇m.
4. Discussion
Microsurgical interventions with ventral root reimplantation
have been widely used to restore target innervation and
functional recovery after brachial plexus injury. However, the
overall outcome of these surgical strategies with respect to
the entire arm function remains poor. A possible reason is
that the number of regenerating motoneurons which send
out axons to innervate peripheral targets is not sufficient
to achieve a significant recovery of function. It has been
suggested that a combination of various approaches may be
more effective for motoneuron survival and axonal regen-
eration in the treatment of avulsion lesions of the spinal
cord [8].Therefore, various combinatory strategies have been
adopted in animal models to test their efficiency in treating
root avulsion injury. It was reported that BDNF treatment
significantly improved the survival of injured motoneurons
and enhanced the regrowth axon sprouts into the distal stump
of musculocutaneous nerve in a C5 ventral root avulsion-
reimplantation rat model [23]. Single dose application of
CNTF and BDNF improved remyelination of regenerating
nerve fibers after C7 ventral root avulsion and replantation
[24]. Cotreatment with riluzole and GDNF showed sig-
nificantly improved locomotor function accompanied with
the increase in the number of surviving and regenerating
motoneurons after ventral root avulsion injury [25].However,
the difficulty in the administration of neurotrophic factors
and their short half-life period limit their application in
treating CNS traumatic injury. Recently cell replacement
therapies have been applied to treat neurological disorders
and a variety of stem cells have been transplanted into the
ventral horn to treat spinal motoneuron degeneration and
denervation [26–29]. Although some promising phenomena
have been found in these studies, it is still a tremendous
challenge for transplanted cells to integrate precisely within
the complex host circuit and find a way to grow axons within
the lesioned spinal cord into the replanted root.
A direct and efficient treatment for root avulsion injury
is to induce sufficient regeneration of injured motoneurons.
The unfavorable microenvironment of injured spinal cords
is a major obstacle for significant regeneration. The problem
which lies in the treatment for root avulsion injury is that
we know little about how inhibitory signals present in the
avulsed spinal cord influence regeneration. Previous studies
reported that avulsion injury stimulated an activation of
astrocytes, microglia, and macrophages [30, 31], which may
play a negative role in axonal regeneration. Our study shows
that root avulsion triggers an activation of GSK-3𝛽 within
24 hours. This is the first demonstration that the expression
of activated GSK-3𝛽 is elevated in the avulsed spinal cord,
especially in the injured motoneurons and along the ventral
funiculus. It has been reported that GSK-3𝛽 activation
induces the collapse of growth cones of cultured neurons
and suppresses their axon formation [32, 33]. It has also
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been shown that axon growth inhibitors such as chondroitin
sulfate proteoglycans (CSPG) and semaphorins repel axon
extension by activating GSK-3𝛽 [6, 34, 35]. Therefore, GSK-
3𝛽 activity is supposed to be closely involved in influenc-
ing axon elongation of CNS neurons. Several studies have
demonstrated that pharmacological inhibition of GSK-3𝛽
activity results in enhanced axonal growth both in vitro and
in vivo [6, 36, 37], suggesting that regulating GSK-3𝛽 activity
may be a prominent target to improve regeneration after CNS
injury. Our present study shows that systemic application of
lithium, a specific GSK-3𝛽 inhibitor, significantly suppresses
GSK-3𝛽 activation triggered by root avulsion in the injured
spinal cord and increases axonal regeneration of avulsed
motoneurons into replanted ventral roots. In addition, more
dendrites are found to emanate from regenerating neurons
in lithium-treated animals with replanted ventral roots. The
results of our study provide evidence for the first time
that lithium has therapeutic potentials in treatment with
brachial plexus injury due to its potent effects on promoting
axonal regeneration into replanted ventral roots. Interest-
ingly, lithium treatment shows no effects on the survival of
avulsed motoneurons, suggesting that GSK-3𝛽 activity is not
a critical regulator for the survival of injured motoneurons.
Lithium is widely used in humans as an antidepressant
drug. Its administration is easy and convenient. These indi-
cate the prospects of applying lithium to treat brachial plexus
injury. However, it should be noted that even if extensive
axonal regeneration has been induced, it is still far away from
the success of healing the devastating injury. Regenerating
axons need an extensive amount of time to reach targets
and they have to be functionally competent to reinnervate
the paralyzed muscles. Can lithium treatment promote elon-
gation speed of regenerating axons? Can lithium treatment
improve functional competency of regenerating axons and
eventually lead to satisfactory recovery of function? A series
of experiments addressing these issues are warranted in the
coming future in order to fully evaluate the therapeutic
potentials of lithium in treating brachial plexus injury.
Conflict of Interests
The authors declare that they have no competing interests
regarding the publication of this paper.
Authors’ Contribution
Huanxing Su, Kwok-Fai So, and Wutian Wu conceived and
designed the experiments; Qiuju Yuan, Dajiang Qin, Xiaoy-
ing Yang, and Wai-Man Wong performed the experiments;
Huanxing Su, Kwok-Fai So, and Wutian Wu analyzed the
data; Huanxing Su and Wutian Wu wrote the paper.
Acknowledgments
This study was supported by Hong Kong SCI Fund and
Multi-Year Research Grant, University of Macau, MYRG122
(Y1-L3)-ICMS12-SHX and MYRG110 (Y1-L2)-ICMS13-SHX,
and Macao Science and Technology Development Fund
(003/2012/A and 018/2013/A1).
References
[1] G. V. de Ferrari, M. A. Chaco´n, M. I. Barr´ıa et al., “Activation
of Wnt signaling rescues neurodegeneration and behavioral
impairments induced by 𝛽-amyloid fibrils,” Molecular Psychi-
atry, vol. 8, no. 2, pp. 195–208, 2003.
[2] F. Fornai, P. Longone, L. Cafaro et al., “Lithium delays progres-
sion of amyotrophic lateral sclerosis,”Proceedings of theNational
Academy of Sciences of the United States of America, vol. 105, no.
6, pp. 2052–2057, 2008.
[3] L. Meijer, M. Flajolet, and P. Greengard, “Pharmacological
inhibitors of glycogen synthase kinase 3,” Trends in Pharmaco-
logical Sciences, vol. 25, no. 9, pp. 471–480, 2004.
[4] M. Ren, V. V. Senatorov, R. W. Chen, and D. M. Chuang,
“Postinsult treatment with lithium reduces brain damage and
facilitates neurological recovery in a rat ischemia/reperfusion
model,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 100, no. 10, pp. 6210–6215, 2003.
[5] V. V. Senatorov, M. Ren, H. Kanai, H. Wei, and D. M. Chuang,
“Short-term lithium treatment promotes neuronal survival and
proliferation in rat striatum infused with quinolinic acid, an
excitotoxic model of Huntington’s disease,” Molecular Psychia-
try, vol. 9, no. 4, pp. 371–385, 2004.
[6] J. Dill, H. Wang, F. Zhou, and S. Li, “Inactivation of glycogen
synthase kinase 3 promotes axonal growth and recovery in the
CNS,” Journal of Neuroscience, vol. 28, no. 36, pp. 8914–8928,
2008.
[7] T. A. El-Gammal and N. A. Fathi, “Outcomes of surgical
treatment of brachial plexus injuries using nerve grafting and
nerve transfers,” Journal of Reconstructive Microsurgery, vol. 18,
no. 1, pp. 7–15, 2002.
[8] R. G. Hallin, T. Carlstedt, I. Nilsson-Remahl, and M. Risling,
“Spinal cord implantation of avulsed ventral roots in primates;
Correlation between restoredmotor function andmorphology,”
Experimental Brain Research, vol. 124, no. 3, pp. 304–310, 1999.
[9] A. O. Narakas, “Injuries of the brachial plexus and neighboring
peripheral nerves in vertebral fractures and other trauma of the
cervical spine,” Orthopade, vol. 16, no. 1, pp. 81–86, 1987.
[10] J. K. Terzis, M. D. Vekris, and P. N. Soucacos, “Outcomes of
brachial plexus reconstruction in 204 patients with devastating
paralysis,” Plastic and Reconstructive Surgery, vol. 104, no. 5, pp.
1221–1240, 1999.
[11] T. Carlstedt, “Functional recovery after ventral root avulsion
and implantation in the spinal cord,” Clinical Neurology and
Neurosurgery, vol. 95, pp. S109–S111, 1993.
[12] T. Carlstedt, P. Grane, R. G. Hallin, and G. Noren, “Return of
function after spinal cord implantation of avulsed spinal nerve
roots,”The Lancet, vol. 346, no. 8986, pp. 1323–1325, 1995.
[13] T. Carlstedt, P. Anand, R. Hallin, P. V. Misra, G. Nore´n, and
T. Seeferlis, “Spinal nerve root repair and reimplantation of
avulsed ventral roots into the spinal cord after brachial plexus
injury,” Journal of Neurosurgery, vol. 93, no. 2, pp. 237–247, 2000.
[14] H. D. Fournier, P. Menei, R. Khalifa, and P. Mercier, “Ideal
intraspinal implantation site for the repair of ventral root
avulsion after brachial plexus injury in humans. A preliminary
anatomical study,” Surgical and Radiologic Anatomy, vol. 23, no.
3, pp. 191–195, 2001.
BioMed Research International 7
[15] C. F. Hoffmann, E. Marani, V. D. Gert, W. Kamp, and R. T.
Thomeer, “Reinnervation and reimplanted ventral rootlets in
the cervical spinal cord of the cat,” Journal of Neurosurgery, vol.
84, pp. 234–243, 1996.
[16] H. Chai, W. Wu, K. F. So, and H. K. Yip, “Survival and
regeneration of motoneurons in adult rats by reimplantation of
ventral root following spinal root avulsion,” NeuroReport, vol.
11, no. 6, pp. 1249–1252, 2000.
[17] H. Y. Gu, H. Chai, J. Y. Zhang et al., “Survival, regeneration
and functional recovery of motoneurons in adult rats by
reimplantation of ventral root following spinal root avulsion,”
European Journal of Neuroscience, vol. 19, no. 8, pp. 2123–2131,
2004.
[18] H. Su, T. H. Chu, and W. Wu, “Lithium enhances proliferation
and neuronal differentiation of neural progenitor cells in vitro
and after transplantation into the adult rat spinal cord,” Experi-
mental Neurology, vol. 206, no. 2, pp. 296–307, 2007.
[19] C. A. Grimes and R. S. Jope, “Themultifaceted roles of glycogen
synthase kinase 3𝛽 in cellular signaling,” Progress in Neurobiol-
ogy, vol. 65, no. 4, pp. 391–426, 2001.
[20] H. Su, Q. Yuan, D. Qin et al., “Ventral root re-implantation is
better than peripheral nerve transplantation for motoneuron
survival and regeneration after spinal root avulsion injury,”
BioMed Central Surgery, vol. 13, article 21, 2013.
[21] L. Li, W. Wu, L. F. H. Lin, M. Lei, R. W. Oppenheim, and L.
J. Houenou, “Rescue of adult mouse motoneurons from injury-
induced cell death by glial cell line-derived neurotrophic factor,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 92, no. 21, pp. 9771–9775, 1995.
[22] W. Wu, “Potential roles of gene expression change in adult
rat spinal motoneurons following axonal injury: a compar-
ison among c-jun, off-affinity nerve growth factor receptor
(LNGFR), and nitric oxide synthase (NOS),” Experimental
Neurology, vol. 141, pp. 190–200, 1996.
[23] P. Haninec, P. Dubovy´, F. Sˇa´mal, L. Housˇtava, and L. Stejskal,
“Reinnervation of the rat musculocutaneous nerve stump after
its direct reconnection with the C5 spinal cord segment by
the nerve graft following avulsion of the ventral spinal roots:
a comparison of intrathecal administration of brain-derived
neurotrophic factor and Cerebrolysin,” Experimental Brain
Research, vol. 159, no. 4, pp. 425–432, 2004.
[24] E. M. Lang, N. Schlegel, K. Reiners, G. O. Hofmann, M.
Sendtner, and E. Asan, “Single-dose application of CNTF and
BDNF improves remyelination of regenerating nerve fibers
after C7 ventral root avulsion and replantation,” Journal of
Neurotrauma, vol. 25, no. 4, pp. 384–400, 2008.
[25] A. Bergerot, P. J. Shortland, P. Anand, S. P. Hunt, and T.
Carlstedt, “Co-treatment with riluzole and GDNF is necessary
for functional recovery after ventral root avulsion injury,”
Experimental Neurology, vol. 187, no. 2, pp. 359–366, 2004.
[26] D. M. Deshpande, Y. S. Kim, T. Martinez et al., “Recovery from
paralysis in adult rats using embryonic stem cells,” Annals of
Neurology, vol. 60, no. 1, pp. 32–44, 2006.
[27] J. Gao, R. E. Coggeshall, Y. I. Tarasenko, and P. Wu, “Human
neural stem cell-derived cholinergic neurons innervate muscle
in motoneuron deficient adult rats,”Neuroscience, vol. 131, no. 2,
pp. 257–262, 2005.
[28] H. Su, W. Zhang, J. Guo, A. Guo, Q. Yuan, and W. Wu, “Neural
progenitor cells enhance the survival and axonal regeneration
of injured motoneurons after transplantation into the avulsed
ventral horn of adult rats,” Journal of Neurotrauma, vol. 26, no.
1, pp. 67–80, 2009.
[29] H. Wichterle, I. Lieberam, J. A. Porter, and T. M. Jessell,
“Directed differentiation of embryonic stem cells into motor
neurons,” Cell, vol. 110, no. 3, pp. 385–397, 2002.
[30] V. E. Koliatsos,W. L. Price, C. A. Pardo, andD. L. Price, “Ventral
root avulsion: an experimental model of death of adult motor
neurons,” Journal of Comparative Neurology, vol. 342, no. 1, pp.
35–44, 1994.
[31] L. N. Novikov, L. N. Novikova, P. Holmberg, and J. O. Kellerth,
“Exogenous brain-derived neurotrophic factor regulates the
synaptic composition of axonally lesioned and normal adult rat
motoneurons,” Neuroscience, vol. 100, no. 1, pp. 171–181, 2000.
[32] H. Jiang, W. Guo, X. Liang, and Y. Rao, “Both the establishment
and the maintenance of neuronal polarity require active mech-
anisms: critical roles of GSK-3𝛽 and its upstream regulators,”
Cell, vol. 120, no. 1, pp. 123–135, 2005.
[33] N. H. Chadborn, A. I. Ahmed, M. R. Holt et al., “PTEN couples
Sema3A signalling to growth cone collapse,” Journal of Cell
Science, vol. 119, no. 5, pp. 951–957, 2006.
[34] B. J. Eickholt, F. S. Walsh, and P. Doherty, “An inactive pool
of GSK-3 at the leading edge of growth cones is implicated in
Semaphorin 3A signaling,” Journal of Cell Biology, vol. 157, no.
2, pp. 211–217, 2002.
[35] Y. Ito, I. Oinuma, H. Katoh, K. Kaibuchi, and M. Negishi,
“Sema4D/plexin-B1 activates GSK-3𝛽 through R-Ras GAP
activity, inducing growth cone collapse,” EMBO Reports, vol. 7,
no. 7, pp. 704–709, 2006.
[36] J. Mills, M. Digicaylioglu, A. T. Legg et al., “Role of integrin-
linked kinase in nerve growth factor-stimulated neurite out-
growth,” Journal of Neuroscience, vol. 23, no. 5, pp. 1638–1648,
2003.
[37] F. Q. Zhou, J. Zhou, S. Dedhar, Y. H. Wu, and W. D. Snider,
“NGF-induced axon growth is mediated by localized inacti-
vation of GSK-3𝛽 and functions of the microtubule plus end
binding protein APC,”Neuron, vol. 42, no. 6, pp. 897–912, 2004.
